Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
24.1 EUR | -0.41% | +1.47% | -14.69% |
Mar. 27 | TESSENDERLO GROUP : FY-23: Tessenderlo disappoints | |
Mar. 27 | Transcript : Tessenderlo Group NV, 2023 Earnings Call, Mar 27, 2024 |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.71 for the current period. Therefore, the company is undervalued.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-14.69% | 2.17B | C+ | ||
+2.65% | 78.54B | B | ||
+0.77% | 46.91B | A- | ||
-5.76% | 30.31B | C | ||
+12.30% | 18.58B | B | ||
-10.05% | 11.56B | B | ||
+5.14% | 11.11B | A- | ||
-7.50% | 9.81B | - | ||
+6.40% | 9.69B | A- | ||
+5.61% | 9.3B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- TESB Stock
- Ratings Tessenderlo Group nv